The MAFEIP User Community has grown to 224 members from 27 different countries (20 within the European Union). The MAFEIP User Community has increased intensively during 2019, showing that many organisations are aware of the importance of analysing the cost-effectiveness of their innovations.
The Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP) tool intends to support evidence-based decision-making processes for all institutions and users in the health and care sector as it can be used to assess the impact of your innovation in terms of health outcomes and resource use. There are more than 15 cases currently available and more cases will be published during 2020 as a result of the last call for use cases. Within the H2020 projects WE4AHA, DHE and Gatekeeper, the team of Open Evidence is there to support organisations, researchers, or public institutions that want to assess their project’s cost-effectiveness and disseminate about the outcomes of this analyses.
At the AAL Forum 2019 in Aarhus, Prof. Dr. Francisco Lupiáñez-Villanueva and Dr. Frans Folkvord presented the usage of MAFEIP as a resource for the assessment of health and economic outcomes and it received great support from the people participating in the workshop. There was agreement among participants that talking about evaluation is great, but it is necessary to begin performing evaluations in the field.
If you are interested in estimating the health and economic outcomes of your health innovations and interventions, join the MAFEIP community and we will help you to analyse your project!